Rasagiline for the management of Parkinson’s disease

Article Properties
  • Language
    English
  • Publication Date
    2008/03/01
  • Journal
  • Indian UGC (journal)
  • Refrences
    64
  • Citations
    5
  • Khashayar Dashtipour
  • Jack J Chen
  • Mark F Lew
Cite
Dashtipour, Khashayar, et al. “Rasagiline for the Management of Parkinson’s Disease”. Therapy, vol. 5, no. 2, 2008, pp. 203-14, https://doi.org/10.2217/14750708.5.2.203.
Dashtipour, K., Chen, J. J., & Lew, M. F. (2008). Rasagiline for the management of Parkinson’s disease. Therapy, 5(2), 203-214. https://doi.org/10.2217/14750708.5.2.203
Dashtipour K, Chen JJ, Lew MF. Rasagiline for the management of Parkinson’s disease. Therapy. 2008;5(2):203-14.
Citations
Title Journal Journal Categories Citations Publication Date
Effect of particle size versus surface charge on the brain targeting behavior of elastic nanovesicles: In-vitro characterization, comparison between I-optimal and D-optimal statistical optimization and in-vivo pharmacokinetic evaluation Journal of Drug Delivery Science and Technology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
2024
Thin film hydration versus modified spraying technique to fabricate intranasal spanlastic nanovesicles for rasagiline mesylate brain delivery: Characterization, statistical optimization, and in vivo pharmacokinetic evaluation

Drug Delivery and Translational Research
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Science: Mathematics: Instruments and machines
  • Medicine: Public aspects of medicine: Toxicology. Poisons
3 2022
Supported metals on porous solids as heterogeneous catalysts for the synthesis of propargylamines

New Journal of Chemistry
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
2022
Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration

Scientific Reports
  • Medicine
  • Science
  • Science: Science (General)
18 2021
Bisphenol A glucuronidation in patients with Parkinson’s disease NeuroToxicology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
22 2017
Citations Analysis
The category Medicine: Public aspects of medicine: Toxicology. Poisons 3 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Bisphenol A glucuronidation in patients with Parkinson’s disease and was published in 2017. The most recent citation comes from a 2024 study titled Effect of particle size versus surface charge on the brain targeting behavior of elastic nanovesicles: In-vitro characterization, comparison between I-optimal and D-optimal statistical optimization and in-vivo pharmacokinetic evaluation. This article reached its peak citation in 2022, with 2 citations. It has been cited in 5 different journals, 20% of which are open access. Among related journals, the Journal of Drug Delivery Science and Technology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year